A major patient safety investigation has been launched after a fatal NHS wrong medication case involving a lung disease patient who was prescribed the incorrect drug for nearly four years, raising serious concerns about clinical oversight and treatment standards in England.
Daniel Noakes, 48, died in February 2024 after being given medication not licensed for his condition, interstitial lung disease, for an extended period. His case is now part of a wider review involving around 200 patients treated by the same NHS trust.
Four years of incorrect treatment
The NHS wrong medication case centres on the prolonged prescription of Roflumilast, a drug approved for chronic obstructive pulmonary disease but not for interstitial lung disease.
According to internal correspondence from Epsom and St Helier University Hospitals NHS Trust, Mr Noakes had been taking the medication since January 2020 before being informed of the error just nine months prior to his death.
The trust has since acknowledged that the medication was not appropriate for his diagnosis and admitted that earlier intervention could have extended his life.
Missed diagnosis and clinical failings
The case has also highlighted wider clinical shortcomings beyond the NHS wrong medication case itself.
Mr Noakes was first referred to hospital services in 2018 after developing a persistent cough, despite previously being fit, healthy and a non-smoker. He was initially assessed through a specialist cough clinic.
However, the trust later admitted that earlier scans and diagnostic tests were inconsistent with asthma and that a CT scan conducted in early 2019 should have prompted further investigation into interstitial lung disease.
Officials acknowledged that a lack of senior medical input contributed to missed opportunities to properly diagnose and manage the condition.
Family’s response and impact
Mr Noakes’s wife, Laura, described the situation as deeply distressing, saying the family had trusted the healthcare system to provide appropriate care.
She said the revelation of the NHS wrong medication case came as a shock, particularly given the belief that he was receiving specialist treatment.
By the time alternative assessments were considered, including potential eligibility for a lung transplant, his condition had deteriorated significantly.
He later died in hospital after developing pneumonia, with a formal inquest still ongoing.
Wider investigation into patient care
The trust has confirmed that Mr Noakes is one of approximately 200 patients whose treatment is now under review, with around 30 cases linked to the care of a single respiratory consultant.
An independent review by the Royal College of Physicians has been commissioned, focusing on clinical practices and patient outcomes.
The investigation into the NHS wrong medication case has also uncovered concerns about workplace culture, including findings that junior staff may have felt unable to challenge senior clinical decisions.
Accountability and regulatory response
Following the incident, the consultant involved was restricted from clinical duties during the investigation and later left the trust.
Regulatory authorities, including the General Medical Council, have imposed interim conditions while inquiries continue.
The NHS trust has issued an apology to the family and stated that measures have been introduced to prevent similar incidents, including strengthened oversight and governance procedures.
Legal representatives for the family have described the case as avoidable and have called for full accountability.
Patient safety concerns in the NHS
The NHS wrong medication case comes amid broader concerns about patient safety, diagnostic delays and workforce pressures within the UK health system.
Medical errors, including incorrect prescriptions and delayed diagnoses, have been identified in previous reviews as significant contributors to preventable harm.
In recent years, NHS organisations have faced increasing scrutiny over clinical governance, staffing shortages and the ability of junior staff to raise concerns.
Experts say improving transparency, strengthening reporting systems and ensuring adherence to evolving medical guidelines are critical to preventing similar incidents.
Ongoing questions and next steps
The outcome of the external review and the ongoing inquest will be key in determining the full extent of the failures in this NHS wrong medication case.
For the family, the focus remains on securing answers and ensuring lessons are learned.
The case has also prompted calls for patients who may have concerns about their care to come forward, as investigations into related cases continue.